http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4100300-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C33-28 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-28 |
filingDate | 1977-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1978-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18dbfecfa24eb721dcde21ddd2bc6e73 |
publicationDate | 1978-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4100300-A |
titleOfInvention | P-(substituted and unsubstituted-phenyl)-1-phenyl-2,3-butadien-1-ols as pharmaceutical agents |
abstract | Disclosed are compounds of the class 1-phenyl-2,3-butadien-1-ol e.g. 2-(p-biphenyl)-3,4-pentadien-2-ol, which are useful by reason of their pharmacological activity in animals, e.g., as anti-inflammatory agents and tranquilizers. Said compounds can be prepared, e.g., by reduction of a corresponding 4-substituted-1-phenyl-2-butyne-1-ol with a complex hydride such as lithium aluminum hydride. |
priorityDate | 1975-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 314.